BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36408832)

  • 1. Toward quantification of loop diuretic responsiveness for congestive heart failure.
    Oyama MA; Adin D
    J Vet Intern Med; 2023 Jan; 37(1):12-21. PubMed ID: 36408832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacy.
    Convey V; Huh T; Achilles EJ; Massey LK; McKaba VF; Loughran KA; Kraus MS; Gelzer AR; Crooks AV; Oyama MA
    J Vet Intern Med; 2024; 38(1):71-80. PubMed ID: 38038223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure.
    Loughran KA; Larouche-Lebel É; Huh T; Testani JM; Rao VS; Oyama MA
    J Vet Intern Med; 2020 Nov; 34(6):2253-2264. PubMed ID: 33125814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic Resistance in Heart Failure.
    Gupta R; Testani J; Collins S
    Curr Heart Fail Rep; 2019 Apr; 16(2):57-66. PubMed ID: 30762178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'.
    Li K; Shi R; Luo L
    Curr Probl Cardiol; 2024 Aug; 49(8):102688. PubMed ID: 38821235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD; Singletary GE; Reynolds CA; Trafny DJ; Machen MC; Oyama MA
    J Vet Cardiol; 2012 Mar; 14(1):253-9. PubMed ID: 22364690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure.
    Biegus J; Zymliński R; Testani J; Fudim M; Cox ZL; Guzik M; Iwanek G; Hurkacz M; Raj D; Marciniak D; Ponikowska B; Ponikowski P
    Eur J Heart Fail; 2023 Aug; 25(8):1323-1333. PubMed ID: 37042083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial direct sodium removal in patients with heart failure and diuretic resistance.
    Rao VS; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Ramos-Mastache D; Neville D; Balkcom N; Asher JL; Bellumkonda L; Bigvava T; Shaburishvili T; Bartunek J; Wilson FP; Finkelstein F; Maulion C; Turner JM; Testani JM
    Eur J Heart Fail; 2024 May; 26(5):1215-1230. PubMed ID: 38556717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy.
    Dauw J; Martens P; Tersalvi G; Schouteden J; Deferm S; Gruwez H; De Moor B; Nijst P; Dupont M; Mullens W
    Eur J Heart Fail; 2021 Jul; 23(7):1110-1119. PubMed ID: 33641220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretics Resistance.
    Fernandes J; Costa R; Guerreiro R; Bonifácio D; Rodrigues A; Henriques C; Branco P; Araújo I; Fonseca C
    Acta Med Port; 2023 Mar; 36(3):193-201. PubMed ID: 36762993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
    Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
    Eur J Heart Fail; 2022 Feb; 24(2):385-392. PubMed ID: 34791756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
    Dauw J; Lelonek M; Zegri-Reiriz I; Paredes-Paucar CP; Zara C; George V; Cobo-Marcos M; Knappe D; Shchekochikhin D; Lekhakul A; Klincheva M; Frea S; Miró Ò; Barker D; Borbély A; Nasr S; Doghmi N; de la Espriella R; Singh JS; Bovolo V; Fialho I; Ross NT; van den Heuvel M; Benkouar R; Findeisen H; Alhaddad IA; Al Balbissi K; Barge-Caballero G; Ghazi AM; Bruckers L; Martens P; Mullens W
    ESC Heart Fail; 2021 Dec; 8(6):4685-4692. PubMed ID: 34708555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
    Yeoh SE; Osmanska J; Petrie MC; Brooksbank KJM; Clark AL; Docherty KF; Foley PWX; Guha K; Halliday CA; Jhund PS; Kalra PR; McKinley G; Lang NN; Lee MMY; McConnachie A; McDermott JJ; Platz E; Sartipy P; Seed A; Stanley B; Weir RAP; Welsh P; McMurray JJV; Campbell RT
    Eur Heart J; 2023 Aug; 44(31):2966-2977. PubMed ID: 37210742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.
    Antonietta CM; Calvi E; Faggiano A; Maffeis C; Bosisio M; De Stefano M; Carugo S; Faggiano P
    Curr Heart Fail Rep; 2022 Feb; 19(1):15-25. PubMed ID: 35037162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.